LARIMAR THERAPEUTICS
Larimar Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases. The companyโs lead compound, CTI-1601, is currently being evaluated in a Phase 1 clinical program as a potential treatment for Friedreichโs ataxia, a rare and progressive genetic disease. Larimar also plans to use its intracellular delivery platform to design other fusion proteins to target additional rare diseases characterized by deficiencies in intracellular bioactive compounds.
LARIMAR THERAPEUTICS
Social Links:
Industry:
Biotechnology Medical Therapeutics
Founded:
2005-01-01
Address:
Bala Cynwyd, Pennsylvania, United States
Country:
United States
Website Url:
http://www.larimartx.com
Total Employee:
11+
Status:
Active
Contact:
844-511-9056
Email Addresses:
[email protected]
Total Funding:
250.18 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome Global Site Tag Mobile Non Scaleable Content
Similar Organizations
Adagene
Adagene is a clinical-stage biotech company that specializes in developing immuno-oncology antibodies.
Aerovate Therapeutics
Aerovate Therapeutics is a biotechnology company focused on developing drugs for rare cardiopulmonary disease.
Avistone Pharmaceuticals
Avistone Pharmaceuticals is a clinical-stage biotechnology company focused on precision oncology therapeutics.
Cocrystal Pharma
Cocrystal Pharma, Inc. is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics.
Electra Therapeutics
Electra Therapeutics is a clinical stage biotechnology company developing therapies for cancer and other immunological diseases.
Global Blood Therapeutics
GBT is a clinical-stage biopharmaceutical company developing a therapy for sickle cell disease.
Inhibrx
Inhibrx is a clinical-stage biotechnology company focused on developing a broad pipeline of novel biologic therapeutic candidates.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Magenta Therapeutics
Magenta Therapeutics is a new biotechnology company developing therapeutics that unlock the power of stem cell biology.
OSE Immunotherapeutics
OSE Immunotherapeutics is a clinical-stage biotechnology company focused on developing.
Pluristem Therapeutics
Pluristem Therapeutics is a biotherapy company using placental cells and a 3D technology platform to develop cell therapies for diseases.
Potenza Therapeutics
Potenza Therapeutics is a preclinical-stage biotechnology company focused on building a portfolio of oncology programs.
LENZ Therapeutics
LENZ Therapeutics is a late-stage clinical company developing innovative ophthalmic pharmaceutical products.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Translate Bio
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
Sensei Biotherapeutics
Sensei Biotherapeutics is a clinical-stage biotechnology company specializing in the field of next-generation cancer immunotherapies.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Theolytics
Theolytics is a pre-clinical stage biotechnology company developing next-generation oncolytic viral therapies.
Viracta Therapeutics
Viracta Therapeutics is a precision oncology company focused on new treatment of virus-associated malignancies.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2019-12-18 | Chondrial Therapeutics | Chondrial Therapeutics acquired by Larimar Therapeutics | N/A |
Investors List
Cowen Healthcare Investments
Cowen Healthcare Investments investment in Post-IPO Equity - Larimar Therapeutics
Surveyor Capital
Surveyor Capital investment in Post-IPO Equity - Larimar Therapeutics
Vivo Capital
Vivo Capital investment in Post-IPO Equity - Larimar Therapeutics
RA Capital Management
RA Capital Management investment in Post-IPO Equity - Larimar Therapeutics
Verition Fund Management
Verition Fund Management investment in Post-IPO Equity - Larimar Therapeutics
Adage Capital Management
Adage Capital Management investment in Post-IPO Equity - Larimar Therapeutics
Deerfield
Deerfield investment in Post-IPO Equity - Larimar Therapeutics
Oxford Finance LLC
Oxford Finance LLC investment in Debt Financing - Larimar Therapeutics
MidCap Financial
MidCap Financial investment in Debt Financing - Larimar Therapeutics
Venrock
Venrock investment in Series E - Larimar Therapeutics
Official Site Inspections
http://www.larimartx.com Semrush global rank: 4.19 M Semrush visits lastest month: 2.82 K
- Host name: 74.226.109.208.host.secureserver.net
- IP address: 208.109.226.74
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260